The current status of vaccine development in colorectal cancer.
Chang
David Z
DZ
GI Medical Oncology & Immunology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000276:immunology; D015179:Colorectal Neoplasms / Q000276:immunology / Q000628:therapy*; D018450:Disease Progression; D004353:Drug Evaluation, Preclinical; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D016896:Treatment Outcome
D019496:Cancer Vaccines; D002272:Carcinoembryonic Antigen; D016178:Granulocyte-Macrophage Colony-Stimulating Factor